Literature DB >> 24052788

Ondansetron to treat pruritus due to cholestatic jaundice.

Sarah Dillon1, Joseph D Tobias.   

Abstract

Intractable itching is a symptom of cholestatic liver disease of various causes that is bothersome and difficult to manage. Although treatment of the primary cause of cholestasis is paramount in resolving the issue, given the debilitating consequences of pruritus, symptomatic treatment is frequently necessary. Although many medications including cholestyramine, rifampin, opioid antagonists (i.e., naloxone, naltrexone), phenobarbital, and antihistamines have been used to treat cholestatic-induced pruritus, none has resulted in uniform success. We report anecdotal success with the use of ondansetron to treat pruritus associated with cholestasis following prolonged intensive care unit course of a 16-year-old. The theories accounting for pruritus with cholestasis are presented, treatment options are reviewed, and the role of ondansetron in the treatment of pruritus is discussed.

Entities:  

Keywords:  cholestatic jaundice; ondansetron; pruritus

Year:  2013        PMID: 24052788      PMCID: PMC3775559          DOI: 10.5863/1551-6776-18.3.241

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN: 1551-6776


  28 in total

Review 1.  Ondansetron: a review of its use as an antiemetic in children.

Authors:  C R Culy; N Bhana; G L Plosker
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

2.  A controlled trial of ondansetron in the pruritus of cholestasis.

Authors:  J W O'Donohue; S P Pereira; A C Ashdown; C G Haigh; J R Wilkinson; R Williams
Journal:  Aliment Pharmacol Ther       Date:  2005-04-15       Impact factor: 8.171

3.  Elevations in skin tissue levels of bile acids in human cholestasis: relation to serum levels and topruritus.

Authors:  C N Ghent; J R Bloomer; G Klatskin
Journal:  Gastroenterology       Date:  1977-11       Impact factor: 22.682

4.  Ondansetron for pruritus in child with chronic cholestasis.

Authors:  P Trioche; D Samuel; M Odièvre; P Labrune
Journal:  Eur J Pediatr       Date:  1996-11       Impact factor: 3.183

Review 5.  The itch of liver disease.

Authors:  Nora V Bergasa
Journal:  Semin Cutan Med Surg       Date:  2011-06

Review 6.  Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus.

Authors:  Martin Steinhoff; John Bienenstock; Martin Schmelz; Marcus Maurer; Ed Wei; Tamás Bíró
Journal:  J Invest Dermatol       Date:  2006-08       Impact factor: 8.551

Review 7.  Itch.

Authors:  Gil Yosipovitch; Malcolm W Greaves; Martin Schmelz
Journal:  Lancet       Date:  2003-02-22       Impact factor: 79.321

Review 8.  Toxicity and side effects of ondansetron.

Authors:  A L Finn
Journal:  Semin Oncol       Date:  1992-08       Impact factor: 4.929

9.  The use of naltrexone in the management of severe generalized pruritus in biliary atresia: report of a case.

Authors:  Yuchi Chang; Linda Golkar
Journal:  Pediatr Dermatol       Date:  2008 May-Jun       Impact factor: 1.588

Review 10.  Itch: scratching more than the surface.

Authors:  R Twycross; M W Greaves; H Handwerker; E A Jones; S E Libretto; J C Szepietowski; Z Zylicz
Journal:  QJM       Date:  2003-01
View more
  5 in total

1.  Interventions for chronic pruritus of unknown origin.

Authors:  Andrea Andrade; Chii Yang Kuah; Juliana Esther Martin-Lopez; Shunjie Chua; Volha Shpadaruk; Gloria Sanclemente; Juan Va Franco
Journal:  Cochrane Database Syst Rev       Date:  2020-01-25

2.  Peripheral and spinal 5-HT receptors participate in cholestatic itch and antinociception induced by bile duct ligation in rats.

Authors:  Bin Tian; Xue-Long Wang; Ya Huang; Li-Hua Chen; Ruo-Xiao Cheng; Feng-Ming Zhou; Ran Guo; Jun-Cheng Li; Tong Liu
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379

3.  BAM8-22 and its receptor MRGPRX1 may attribute to cholestatic pruritus.

Authors:  Babina Sanjel; Han-Joo Maeng; Won-Sik Shim
Journal:  Sci Rep       Date:  2019-07-26       Impact factor: 4.379

Review 4.  Pruritus in Systemic Diseases: A Review of Etiological Factors and New Treatment Modalities.

Authors:  Nagihan Tarikci; Emek Kocatürk; Şule Güngör; Ilteriş Oğuz Topal; Pelin Ülkümen Can; Ralfi Singer
Journal:  ScientificWorldJournal       Date:  2015-07-09

Review 5.  Serotonin: A Potent Immune Cell Modulator in Autoimmune Diseases.

Authors:  Minjie Wan; Lili Ding; Dong Wang; Jiawen Han; Pujun Gao
Journal:  Front Immunol       Date:  2020-02-11       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.